Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

Lisa Riley has described herself as a 'self-confessed control freak' as she revealed the reason why she has chosen not to ...

Emmerdale actress Lisa Riley shared that she felt there was "no way out" after appearing on Strictly Come Dancing amid her ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

With the average age for women to be diagnosed with breast cancer is late forties, one woman revealed she was diagnosed with ...

Arizona State Retirement System grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 12.4% during the ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.

The American Association for Cancer Research (AACR) today announced its newly elected 2025 class of Fellows of the AACR Academy.